Hartaj Singh, Equity Analyst at Oppenheimer, says that more governments are coming to Moderna for their manufacturing process and their efficacy. He adds that increased certainty in revenues in this year and next has helped increase the stock price.
25 Feb 2021
Morning Trade Live
09 Nov 2020
Morning Trade Live
07 Dec 2020
Market On Close
23 Nov 2020
Morning Trade Live
25 Jan 2021
The Watch List
15 Jan 2021
Hartaj Singh, Equity Analyst at Oppenheimer, says that more governments are coming to Moderna for their manufacturing process and their efficacy. He adds that increased certainty in revenues in this year and next has helped increase the stock price.
25 Feb 2021